边缘性角膜溃疡的研究现状
Research Status of Marginal CornealUlcer
DOI: 10.12677/HJO.2023.121005, PDF,   
作者: 崔淑敏, 李 新*:蚌埠市第二人民医院眼科,安徽 蚌埠
关键词: 边缘性角膜溃疡自身免疫性疾病治疗Peripheral Ulcerative Keratitis Autoimmune Disease Treatment
摘要: 边缘性角膜溃疡(Peripheral Ulcerative Keratitis, PUK)是一种主要发生在角膜边缘的新月型的炎症性疾病,主要表现为角膜上皮缺损和角膜基质破坏;主要与自身免疫及边缘角膜的特殊解剖部位及生理学特征及环境等因素有关。PUK可能是局部或全身的感染及非感染性病因所致。本综述总结了与非感染性PUK相关的临床特征、发病机制和疾病,以及近期开发的治疗方案。
Abstract: Peripheral ulcerative keratitis (PUK) is a crescent-shaped inflammatory disease that mainly occurs in the corneal margin, and its manifestations are corneal epithelial defect and corneal stromal destruction. It is mainly related to autoimmunity, special anatomical and physiological features of marginal cornea and environmental factors. PUK may be due to local or systemic infection and non-infectious etiology. This review summarizes the clinical features, pathogenesis, and disease associated with non-infectious PUK, as well as recently developed treatment options.
文章引用:崔淑敏, 李新. 边缘性角膜溃疡的研究现状[J]. 眼科学, 2023, 12(1): 31-37. https://doi.org/10.12677/HJO.2023.121005

参考文献

[1] McKibbin, M., Isaacs, J.D. and Morrell, A.J. (1999) Incidence of Corneal Melting in Association with Systemic Disease in the Yorkshire Region, 1995-7. British Journal of Ophthalmology, 83, 941-943.
[Google Scholar] [CrossRef] [PubMed]
[2] Odorcic, S., Keystone, E.C. and Ma, J.J.K. (2009) Infliximab for the Treatment of Refractory Progressive Sterile Peripheral Ulcerative Keratitis Associated with Late Corneal Perforation: 3-Year Follow-Up. Cornea, 28, 89-92.
[Google Scholar] [CrossRef
[3] Ladas, J.G. and Mondino, B.J. (2000) Systemic Disorders Associated with Peripheral Corneal Ulceration. Current Opinion in Ophthalmology, 11, 468-471.
[Google Scholar] [CrossRef] [PubMed]
[4] Akpek, E.K., Thorne, J.E., Qazi, F.A., et al. (2004) Evaluation of PATIENTS with Scleritis for Systemic Disease. Ophthalmology, 111, 501-506.
[Google Scholar] [CrossRef] [PubMed]
[5] Tauber, J., Sainz, D.L.M., Hoang-Xuan, T., et al. (1990) An Analysis of Therapeutic Decision Making Regarding Immunosuppressive Chemotherapy for Peripheral Ulcerative Keratitis. Cornea, 9, 66-73.
[Google Scholar] [CrossRef
[6] Messmer, E.M. and Foster, C.S. (1999) Vasculitic Peripheral Ulcerative Keratitis. Survey of Ophthalmology, 43, 379-396.
[Google Scholar] [CrossRef
[7] Foster, C.S., Forstot, S.L. and Wilson, L.A. (1984) Mortality Rate in Rheumatoid Arthritis Patients Developing Necrotizing Scleritis or Peripheral Ulcerative Keratitis. Effects of Systemic Immunosuppression. Ophthalmology, 91, 1253-1263.
[Google Scholar] [CrossRef
[8] Gupta, Y., Kishore, A., Kumari, P., et al. (2021) Peripheral Ulcerative Keratitis. Survey of Ophthalmology, 66, 977-998.
[Google Scholar] [CrossRef] [PubMed]
[9] Gonzalez, G., Sasamoto, Y., Ksander, B.R., et al. (2017) Limbal Stem Cells: Identity, Developmental Origin, and Therapeutic Potential. Wiley Interdisciplinary Reviews: Developmental Biology, 7, e303.
[Google Scholar] [CrossRef] [PubMed]
[10] Robin, J.B., Schanzlin, D.J., Verity, S.M., et al. (1986) Peripheral Corneal Disorders. Survey of Ophthalmology, 31, 1-36.
[Google Scholar] [CrossRef] [PubMed]
[11] Marsovszky, L., Resch, M.D., Németh, J., Toldi, G., et al. (2013) In Vivo Confocal Microscopic Evaluation of Corneal Langerhans Cell Density, and Distribution and Evaluation of Dry Eye in Rheumatoid Arthritis. Innate Immunity, 19, 348-354.
[Google Scholar] [CrossRef] [PubMed]
[12] Messmer, E.M. and Foster, C.S. (1995) Destructive Corneal and Scleral Disease Associated with Rheumatoid Arthritis. Medical and Surgical Management. Cornea, 14, 408-417.
[Google Scholar] [CrossRef] [PubMed]
[13] Müller, L.J., Pels, E., Schurmans, L., et al. (2004) A New Three-Dimensional Model of the Organization of Proteoglycans and Collagen Fibrils in the Human Corneal Stroma. Experimental Eye Research, 78, 493-501.
[Google Scholar] [CrossRef
[14] Müller, L.J., Vrensen, G.F., Pels, L., et al. (1997) Architecture of Human Corneal Nerves. Investigative Ophthalmology & Visual Science, 38, 985-994.
[15] Dana, M.R., Qian, Y. and Hamrah, P. (2000) Twenty-Five-Year Panorama of Corneal Immunology: Emerging Concepts in the Immunopathogenesis of Microbial Keratitis, Peripheral Ulcerative Keratitis, and Corneal Transplant Rejection. Cornea, 19, 625.
[Google Scholar] [CrossRef] [PubMed]
[16] Foster, C.S., Kenyon, K.R., Greiner, J., et al. (1979) The Immunopathology of Mooren’s Ulcer. American Journal of Ophthalmology, 88, 149-159.
[Google Scholar] [CrossRef] [PubMed]
[17] Mondino, B.J., Brown, S.I. and Rabin, B.S. (1978) Cellular Immunity in Mooren’s Ulcer. American Journal of Ophthalmology, 85, 788-791.
[Google Scholar] [CrossRef
[18] Mondino, B.J. (1988) Inflammatory Diseases of the Peripheral Cornea. Ophthalmology, 95, 463-472.
[Google Scholar] [CrossRef
[19] Keenan, J.D., Mandel, M.R. and Margolis, T.P. (2011) Peripheral Ulcerative Keratitis Associated with Vasculitis Manifesting Asymmetrically as Fuchs Superficial Marginal Keratitis and Terrien Marginal Degeneration. Cornea, 30, 825.
[Google Scholar] [CrossRef
[20] Gregory, J.K. and Foster, C.S. (1996) Peripheral Ulcerative Keratitis in the Collagen Vascular Diseases. International Ophthalmology Clinics, 36, 21-30.
[Google Scholar] [CrossRef] [PubMed]
[21] Fernandes, S.R.M., Singsen, B.H. and Hoffman, G.S. (2000) Sarcoidosis and Systemic Vasculitis. Seminars in Arthritis & Rheumatism, 30, 33-46.
[Google Scholar] [CrossRef] [PubMed]
[22] Riley, G.P., Harrall, R.L., Watson, P.G., et al. (1995) Collagenase (MMP-1) and TIMP-1 in Destructive Corneal Disease Associated with Rheumatoid Arthritis. Eye, 9, 703.
[Google Scholar] [CrossRef] [PubMed]
[23] Perry, H.D. and Golub, L.M. (1986) Systemic Tetracyclines in the Treatment of Noninfected Corneal Ulcers: A Case Report and Proposed New Mechanism of Action. Annals of Ophthalmology, 17, 742-744.
[24] Ralph, R.A. (2000) Tetracyclines and the Treatment of Corneal Stromal Ulceration. Cornea, 19, 274-277.
[Google Scholar] [CrossRef] [PubMed]
[25] Kaçmaz, R.O., Kempen, J.H., Newcomb, C., et al. (2010) Cyclosporine for Ocular Inflammatory Diseases. Ophthalmology, 117, 576-584.
[Google Scholar] [CrossRef] [PubMed]
[26] Golub, L.M. (1991) Tetracyclines Inhibit Connective Tissue Breakdown: New Therapeutic Implications for an Old Family of Drugs. Critical Reviews in Oral Biology and Medicine: An Official Publication of the American Association of Oral Biologists, 2, 297-321.
[Google Scholar] [CrossRef] [PubMed]
[27] Galor, A. and Thorne, J.E. (2007) Scleritis and Peripheral Ulcerative Keratitis. Rheumatic Disease Clinics of North America, 33, 835-854.
[Google Scholar] [CrossRef] [PubMed]
[28] Jabs, D.A., Rosenbaum, J.T., Foster, C.S., et al. (2000) Guidelines for the Use of Immunosuppressive Drugs in Patients with Ocular Inflammatory Disorders: Recommendations of an Expert Panel. American Journal of Ophthalmology, 130, 492-513.
[Google Scholar] [CrossRef
[29] Sainz de la Maza, M., Foster, C.S., Jabbur, N.S. and Baltatzis, S. (2002) Ocular Characteristics and Disease Associations in Scleritis-Associated Peripheral Keratopathy. Archives of Ophthalmology, 120, 15-19.
[Google Scholar] [CrossRef] [PubMed]
[30] Squirrell, D.M., Winfield, J. and Amos, R.S. (1999) Peripheral Ulcerative Keratitis “Corneal Melt” and Rheumatoid Arthritis: A Case Series. Rheumatology, 38, 1245-1248.
[Google Scholar] [CrossRef] [PubMed]
[31] Messmer, E.M. and Foster, C.S. (1999) Vasculitic Peripheral Ulcerative Keratitis. Survey of Ophthalmology, 43, 379-396.
[Google Scholar] [CrossRef
[32] Sato, T., Minakuchi, S., Mochizuki, M. and Takeuchi, M. (2014) Acute Anterior Uveitis after Discontinuation of Tocilizumab in a Patient with Rheumatoid Arthritis. Clinical Ophthalmology, 8, 187-190.
[Google Scholar] [CrossRef
[33] Stylianides, A., Jones, M.N., Stewart, R.M., et al. (2013) Rheumatoid Arthritis-Associated Corneal Ulceration: Mortality and Graft Survival. Ophthalmology, 120, 682-686.
[Google Scholar] [CrossRef] [PubMed]
[34] Galor, A., Jabs, D.A., Leder, H.A., et al. (2008) Comparison of Antimetabolite Drugs as Corticosteroid-Sparing Therapy for Noninfectious Ocular Inflammation. Ophthalmology, 115, 1826-1832.
[Google Scholar] [CrossRef] [PubMed]
[35] Mccarthy, J.M., Dubord, P.J., Chalmers, A., et al. (1992) Cyclosporine A for the Treatment of Necrotizing Scleritis and Corneal Melting in Patients with Rheumatoid Arthritis. Journal of Rheumatology, 19, 1358-1361.
[36] Thomas, J.W. and Pflugfelder, S.C. (2005) Therapy of Progressive Rheumatoid Arthritis-Associated Corneal Ulceration with Infliximab. Cornea, 24, 742.
[Google Scholar] [CrossRef] [PubMed]
[37] Antao, S.F., Ayoub, T., Tahir, H., et al. (2012) Stabilization of Bilateral Progressive Rheumatoid Corneal Melt with Infliximab. Case Reports in Ophthalmological Medicine, 2012, Article ID: 173793.
[Google Scholar] [CrossRef] [PubMed]
[38] Atchia, I.I., Kidd, C.E. and Bell, R.W.D. (2006) Rheumatoid Arthritis-Associated Necrotizing Scleritis and Peripheral Ulcerative Keratitis Treated Successfully with Infliximab. Journal of Clinical Rheumatology Practical Reports on Rheumatic & Musculoskeletal Diseases, 12, 291-293.
[Google Scholar] [CrossRef] [PubMed]
[39] Kawabata, Y., Miyaji, Y., Nakano, T., et al. (2012) A Change in Treatment from Etanercept to Infliximab Was Effective to Control Scleritis in a Patient with Rheumatoid Arthritis. Acta Ophthalmologica, 90, e161-e162.
[Google Scholar] [CrossRef] [PubMed]
[40] Ashok, D., Ayliffe, W.H. and Kiely, P. (2005) Necrotizing Scleritis Associated with Rheumatoid Arthritis: Long-Term Remission with High-Dose Infliximab Therapy. Rheumatology, 44, 950-951.
[Google Scholar] [CrossRef] [PubMed]
[41] Smith, J.R., Levinson, R., Holland, G.N., et al. (2001) Differential Efficacy of Tumor Necrosis Factor Inhibition in the Management of Inflammatory Eye Disease and Associated Rheumatic Disease. Arthritis & Rheumatology, 45, 252-257.
[Google Scholar] [CrossRef
[42] García, C.C., Rosso, M.L., Bertoni, M.D., et al. (2017) Necrotising Scleritis and Peripheral Ulcerative Keratitis Associated with Rheumatoid Arthritis Treated with Rituximab. KlinischeMonatsblätter für Augenheilkunde, 234, 567-570.
[Google Scholar] [CrossRef] [PubMed]
[43] Freidlin, J., Wong, I.G. and Acharya, N. (2007) Rituximab Treatment for Peripheral Ulcerative Keratitis Associated with Wegener’s Granulomatosis. British Journal of Ophthalmology, 91, 1414.
[Google Scholar] [CrossRef] [PubMed]
[44] Feder, R.S. and Krachmer, J.H. (1984) Conjunctival Resection for the Treatment of the Rheumatoid Corneal Ulceration. Ophthalmology, 91, 111-115.
[Google Scholar] [CrossRef
[45] Vera, L., Benzerroug, M., Gueudry, J., et al. (2009) Mise au point sur l’utilisation des colles tissulaires en ophtalmologie. Journal Français d’Ophtalmologie, 32, 290-305.
[Google Scholar] [CrossRef] [PubMed]
[46] Maeno, A., Naor, J., Lee, H.M., Hunter, W.S. and Rootman, D.S. (2000) Three Decades of Corneal Transplantation: Indications and Patient Characteristics. Cornea, 19, 7-11.
[Google Scholar] [CrossRef] [PubMed]
[47] Artifoni, M., et al. (2014) Ocular Inflammatory Diseases Associated with Rheumatoid Arthritis. Nature Reviews Rheumatology, 10, 108-116.
[Google Scholar] [CrossRef] [PubMed]